These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 6110672)

  • 41. Comparison of binding of bovine and human thyroid-stimulating hormone to receptor sites on human thyroid membranes.
    Kermode JC; Thompson BD; Edmonds CJ
    J Endocrinol; 1981 Feb; 88(2):205-17. PubMed ID: 6259266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.
    Baker JR; Lukes YG; Burman KD
    J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding site.
    Piraphatdist T; Sugawa H; Inoue D; Enomoto T; Mori T; Imura H
    Biochem Biophys Res Commun; 1990 Oct; 172(2):529-36. PubMed ID: 1978673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease.
    Zakarija M; Garcia A; McKenzie JM
    J Clin Invest; 1985 Nov; 76(5):1885-91. PubMed ID: 2997295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study of the binding of Graves' immunoglobulins by the patients own and other thyroid membranes.
    Gossage AA; Byfield PG; Copping S; Himsworth RL
    Clin Endocrinol (Oxf); 1981 Mar; 14(3):301-10. PubMed ID: 6894892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis.
    Tokuda Y; Kasagi K; Iida Y; Hatabu H; Misaki T; Arai K; Endo K; Konishi J
    J Clin Endocrinol Metab; 1988 Aug; 67(2):251-8. PubMed ID: 2899088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interaction of thyrotrophin binding inhibiting immunoglobulins with high and low affinity TSH receptors.
    Pekonen F; Mäkinen T
    Acta Endocrinol Suppl (Copenh); 1983; 251():33-7. PubMed ID: 6132509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition by certain plant extracts of the binding and adenylate cyclase stimulatory effect of bovine thyrotropin in human thyroid membranes.
    Auf'mkolk M; Ingbar JC; Amir SM; Winterhoff H; Sourgens H; Hesch RD; Ingbar SH
    Endocrinology; 1984 Aug; 115(2):527-34. PubMed ID: 6745167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solubilized human thyrotrophin receptors behave as one class of high-affinity binding sites.
    de Bruin TW; van der Heide D
    Mol Cell Endocrinol; 1984 Oct; 37(3):337-48. PubMed ID: 6094287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of TBII activity in untreated Graves' disease using solubilised thyroid membranes.
    Taylor JJ; Young ET; Holcombe M; Kendall-Taylor P
    Ann Clin Biochem; 1985 Jul; 22 ( Pt 4)():366-70. PubMed ID: 2864013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases.
    Tao TW; Kriss JP
    J Clin Endocrinol Metab; 1982 Nov; 55(5):935-40. PubMed ID: 6126489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Properties of thyrotropin (TSH) binding to plasma membranes prepared from rat fat tissues.
    Kaise K; Kaise N; Yoshida K; Itagaki Y; Kiso Y; Arai T; Yamamoto M; Sakurada T; Saito S; Yoshinaga K
    Tohoku J Exp Med; 1988 Feb; 154(2):115-24. PubMed ID: 3381221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
    Leedman PJ; Frauman AG; Colman PG; Michelangeli VP
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different binding of stimulatory-type and blocking-type TSH receptor antibody with guinea-pig testis membrane.
    Inui T; Ochi Y; Hachiya T; Chen W; Nakajima Y; Kajita Y; Ogura H
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):563-9. PubMed ID: 1684686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyrotropin binding to cultured lymphocytes and thyroid cells.
    Pekonen F; Weintraub BD
    Endocrinology; 1978 Nov; 103(5):1668-77. PubMed ID: 34508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous measurement of TSH-binding inhibitor immunoglobulin and thyroid stimulating autoantibody activities using cultured FRTL-5 cells in patients with untreated Graves' disease.
    Lu C; Kasagi K; Hidaka A; Hatabu H; Iida Y; Konishi J
    Acta Endocrinol (Copenh); 1990 Sep; 123(3):282-90. PubMed ID: 1978457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of human and porcine thyroid membranes for radioreceptor assay of bovine thyrotrophin and thyrotrophin-binding inhibiting immunoglobulins.
    Humphries H; Dirmikis SM; Munro DS
    J Endocrinol; 1982 Jun; 93(3):371-80. PubMed ID: 6123540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence and specificities of labeled thyrotropic hormone (TSH) binding immunoglobulins (LTB-Igs) in patients with Graves' disease and other thyroid disorders.
    Akamizu T; Mori T; Ishii H; Yokota T; Nakamura H; Imura H
    Jpn J Med; 1986 Feb; 25(1):13-9. PubMed ID: 3754912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.